Improvements in surgical results for lung cancer from 1989 to 1999 in Japan
- PMID: 19861906
- DOI: 10.1097/JTO.0b013e3181ba2054
Improvements in surgical results for lung cancer from 1989 to 1999 in Japan
Abstract
Background: In 1986, Japanese Association for Thoracic Surgery started a nationwide survey of the number of primary lung cancer undergoing resection and this survey was continued annually. Thereafter, investigations of lung cancer surgical results have been conducted three times. The postoperative overall 5-year survival rate was 47.8% in resected cases in 1989, 52.3% in 1994, and 62.0% in 1999, showing improvement over the decade (p < 0.01).
Objective: To clarify the factors influencing survival improvements retrospectively.
Patients and methods: The subjects of the investigation are the patients who underwent resection for primary lung cancers in 1989, 1994, and 1999. Postoperatively, after 5 years, surveys of surgical results were sent to institutes where lung cancer resection had been performed. The subjects undergoing resection who provided 10 items (age, sex, pathologic T factor, pathologic N factor, pathologic M factor, date of resection, histology, curability, prognosis, and survival time) numbered 3004 in 1989, 6895 in 1994, and 12,235 in 1999. They were classified according to the Union International Contre le Cancer 1997 revised tumor, node, and metastasis classification. Differences in age, gender, histology, pathologic stage, curability, and operative death rates were analyzed for each survey year.
Results: According to the changes in proportions, the cases over 70 years of age, women, and pathologic stage I increased significantly (p < 0.001), whereas in cases with small cell lung cancer, incomplete resection and operative death decreased significantly over time (p < 0.001).
Conclusion: The postoperative 5-year survival rate in Japan improved between 1989 and 1999. The main cause of this improvement was the increase in early stage lung cancer, especially cases with tumors 2 cm or less in size.
Similar articles
-
Analysis of survival in 400 surgically resected non-small cell lung carcinomas: towards a redefinition of the T factor.J Thorac Oncol. 2008 Sep;3(9):989-93. doi: 10.1097/JTO.0b013e3181838b19. J Thorac Oncol. 2008. PMID: 18758301
-
Long-term survival after video-assisted thoracic surgery lobectomy for primary lung cancer.Ann Thorac Surg. 2010 Feb;89(2):353-9. doi: 10.1016/j.athoracsur.2009.10.034. Ann Thorac Surg. 2010. PMID: 20103297
-
Impact of tumor size on outcomes after anatomic lung resection for stage 1A non-small cell lung cancer based on the current staging system.J Thorac Cardiovasc Surg. 2012 Feb;143(2):390-7. doi: 10.1016/j.jtcvs.2011.10.023. Epub 2011 Dec 9. J Thorac Cardiovasc Surg. 2012. PMID: 22169444
-
Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.Ann Thorac Surg. 2004 Oct;78(4):1200-5; discussion 1206. doi: 10.1016/j.athoracsur.2004.04.085. Ann Thorac Surg. 2004. PMID: 15464470 Review.
-
Trends and current status of general thoracic surgery in Japan revealed by review of nationwide databases.J Thorac Dis. 2016 Aug;8(Suppl 8):S589-95. doi: 10.21037/jtd.2016.06.44. J Thorac Dis. 2016. PMID: 27651932 Free PMC article. Review.
Cited by
-
A proteomic profiling of laser-microdissected lung adenocarcinoma cells of early lepidic-types.Clin Transl Med. 2015 Dec;4(1):64. doi: 10.1186/s40169-015-0064-3. Epub 2015 Jul 3. Clin Transl Med. 2015. PMID: 26162278 Free PMC article.
-
Circulating tumor cells (CTCs) in lung cancer: current status and future perspectives.Lung Cancer (Auckl). 2010 Jul 3;1:77-84. doi: 10.2147/lctt.s6828. eCollection 2010. Lung Cancer (Auckl). 2010. PMID: 28210108 Free PMC article. Review.
-
Is lobe specific lymph node dissection adequate for cN0-1 non-small cell lung cancer?J Cardiothorac Surg. 2020 Feb 27;15(1):46. doi: 10.1186/s13019-020-1087-4. J Cardiothorac Surg. 2020. PMID: 32106870 Free PMC article.
-
Clinical characteristics and outcomes of patients with small cell lung cancer detected by CT screening.Med Oncol. 2013;30(3):623. doi: 10.1007/s12032-013-0623-7. Epub 2013 Jun 6. Med Oncol. 2013. PMID: 23740004
-
Matrix metalloproteinase‑1 and microRNA‑486‑5p in urinary exosomes can be used to detect early lung cancer: A preliminary report.Oncol Lett. 2024 Jan 29;27(3):127. doi: 10.3892/ol.2024.14261. eCollection 2024 Mar. Oncol Lett. 2024. PMID: 38333640 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical